Medicare Enrolled

Dr. Jeffrey Fraser, DO

Family Medicine · Venice, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1720 E VENICE AVE, Venice, FL 34292
9414839730
In practice since 2006 (19 years)
NPI: 1740292762 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fraser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fraser? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fraser

Dr. Jeffrey Fraser is a family medicine in Venice, FL, with 19 years in practice. Based on federal Medicare data, Dr. Fraser performed 11,053 Medicare services across 6,730 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fraser received a total of $3,739 from 31 pharmaceutical and/or device companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fraser is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in FL$ $3,739 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,053
Medicare services
Top 2% in FL for family medicine
6,730
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~582 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,581$18$47
Office visit, established patient (30-39 min)1,428$88$264
Blood draw (venipuncture)772$8$17
Comprehensive metabolic blood panel636$10$21
Complete blood count (CBC) with differential572$8$16
Annual wellness visit, follow-up568$128$267
Lipid panel (cholesterol and triglycerides)536$13$27
Thyroid stimulating hormone (TSH) test510$16$34
Hemoglobin A1c test (diabetes monitoring)478$10$19
Annual depression screening373$18$38
Office visit, established patient (20-29 min)188$57$187
Free thyroxine (T4) test184$9$18
Flu vaccine administration178$30$64
Flu vaccine, high-dose175$72$144
Vitamin D level test158$29$59
Pneumonia vaccine administration144$30$64
Vitamin B-12 level test132$15$30
Pneumococcal vaccine, 23-valent126$131$267
Prothrombin time test (blood clotting)96$4$9
Urine microalbumin test (kidney screening)92$6$12
Creatinine test (kidney function)92$5$10
Prostate cancer screening; prostate specific antigen test (psa)90$19$39
Urinalysis, manual74$3$7
PSA test (prostate cancer screening)69$18$37
Transitional care management services for problem of high complexity61$215$570
Drug injection, under skin or into muscle60$9$30
Uric acid level test55$4$9
Electrocardiogram (EKG), 12-lead51$11$30
Urine culture, bacterial colony count46$8$16
Ferritin level test (iron stores)39$13$27
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and38$40$107
Iron level test37$6$13
Iron binding capacity test37$9$17
Glutamyltransferase (liver enzyme) level34$7$14
C-reactive protein test (inflammation marker)30$5$10
Natriuretic peptide (heart and blood vessel protein) level29$38$79
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a28$30$86
Sed rate test (inflammation marker)25$3$5
Transitional care management services for problem of at least moderate complexity23$157$420
New patient office visit (45-59 min)20$119$347
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use18$267$577
Amylase (enzyme) level17$6$13
Lipase (fat enzyme) level17$7$14
Bacterial culture, aerobic17$8$16
Antibiotic sensitivity test17$8$17
Urinalysis with microscopic exam16$3$6
Folic acid level test16$14$29
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment16$166$343
Automated urinalysis14$2$4
Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report14$9$30
Testing for presence of drug, read by direct observation13$12$25
New patient office visit (30-44 min)13$76$235
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,739
Total received (2018-2024)
Avg $623/year across 6 years
Top 14% in FL for family medicine
31
Companies
241
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,739 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$253
2023
$172
2022
$546
2020
$198
2019
$1,158
2018
$1,411

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$495
PFIZER INC.
$354
AstraZeneca Pharmaceuticals LP
$326
Novo Nordisk Inc
$318
Merck Sharp & Dohme Corporation
$268
Astellas Pharma US Inc
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$237
Amgen Inc.
$226
Lilly USA, LLC
$179
SANOFI-AVENTIS U.S. LLC
$140
Takeda Pharmaceuticals U.S.A., Inc.
$131
Boston Scientific Corporation
$110
Kowa Pharmaceuticals America, Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$103
Sunovion Pharmaceuticals Inc.
$59
Allergan Inc.
$53
Bayer Healthcare Pharmaceuticals Inc.
$45
Biohaven Pharmaceutical Holding Company Ltd.
$41
Abbott Laboratories
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
Dexcom, Inc.
$36
Amarin Pharma Inc.
$24
Janssen Pharmaceuticals, Inc
$22
Circassia Pharmaceuticals Inc
$20
Antares Pharma, Inc.
$19
Xeris Pharmaceuticals, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$15
Merck Sharp & Dohme LLC
$14
IDORSIA PHARMACEUTICALS US INC
$14
Aytu BioScience, Inc
$13
Radius Health, Inc.
$13
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · ANORO · Aimovig · BAQSIMI · BASAGLAR · BEVESPI AEROSPHERE · BREO · BROVANA · CHANTIX · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GENERAL THERAPIES · GVOKE PFS · JANUVIA · JARDIANCE · Kerendia · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MYRBETRIQ · Myrbetriq · NURTEC ODT · Natesto · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 20 · Prolia · QUVIVIQ · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · Tresiba · Trintellix · Tymlos · VESICARE · VIBERZI · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · XYOSTED · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $34 per 100 Medicare services performed
Looking for a family medicine in Venice?
Compare family medicines in the Venice area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
318
Per 100K population
70.8
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
6.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fraser is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fraser experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Fraser performed 2,581 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fraser receive payments from pharmaceutical companies?
Yes. Dr. Fraser received a total of $3,739 from 31 companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fraser's costs compare to other family medicines in Venice?
Dr. Fraser's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fraser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →